Eyebot gets $20M Series A to boost to expand eye care access | TechCrunch
Briefly

Eyebot operates self-service kiosks that deliver a free, 90-second vision test and generate prescriptions. Each prescription is reviewed and approved by licensed eye doctors under clinical supervision. Kiosks are deployed in malls, universities, retail stores, pharmacies, grocery chains, schools and airports, increasing accessibility and eliminating appointment delays, insurance complexity and cost barriers. The startup secured $20 million in Series A financing, bringing total funding above $30 million. More than 45,000 free vision tests have been conducted, with an annual delivery target exceeding half a million. Tests flag unusual results for referral to in-person comprehensive exams.
Eyebot, a startup offering a 90-second vision test kiosk that delivers doctor-verified glasses prescriptions, has secured $20 million in Series A funding. The Boston-based startup, founded in 2021, streamlines how people access vision care by eliminating traditional obstacles, such as appointment delays, limited accessibility, complex insurance requirements, and cost. Its kiosks, already found in malls, universities, retail stores, pharmacies, grocery chains, schools, and airports, deliver a free, 90-second vision test.
According to the company, each test generates a prescription that is then reviewed and approved by licensed eye doctors, ensuring fast, convenient, and reliable prescriptions. The new funding, which brings Eyebot's total funding to more than $30 million, comes roughly a year after the startup raised its seed round in June 2024. Since then, the startup has conducted more than 45,000 free vision tests and is on track to deliver over half a million annually, it says.
Read at TechCrunch
[
|
]